Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | ||
Founding Date | Founding Date 2013 | Founding Date 2011 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations København, DK HQ | Locations Montpellier, FR HQ Grabels, FR |
Employees | Employees 7 | Employees 614% decrease |

SurgiMab is a company that develops of intraoperative detection of tumors.
View company